Z-0387-2019 Class II Terminated

Recalled by Becton Dickinson & Company — Franklin Lakes, NJ

FDA device recall Z-0387-2019 was initiated by Becton Dickinson & Company on Sep 26, 2018 and is designated Class II. Reason for recall: The products have the potential to leak between the connection of the male luer lock and the yellow striped tubing. The recall status is terminated (terminated Apr 13, 2020). Affected quantity: 566,737 total.

Recall Details

Product Type
Devices
Report Date
Nov 14, 2018
Initiation Date
Sep 26, 2018
Termination Date
Apr 13, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
566,737 total

Product Description

PCEA Kit ASV Yellow Stripe Microbore, Catalog Number 10800177 Product Usage: PCEA Administration Set. Microbore tubing with Yellow Identification Stripe. Anti-siphon valve. Set cannot be used for gravity infusion 1. Connect PCA syringe to female luer on administration set. 2. Push on syringe plunger to prime set. 3. Refer to PCA module directions for Use for complete loading and operating instructions. Notes: The set should be changed according to the facility protocol or in accordance with currently recognized guidelines for IV therapy. Antisiphon sets cannot be primed by gravity.

Reason for Recall

The products have the potential to leak between the connection of the male luer lock and the yellow striped tubing.

Distribution Pattern

Worldwide Distribution - US Nationwide in the states of: AK, AL, AR, AZ, CA, CO, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MD, ME, MI, MO, MT, NC, NE, NJ, NV, NY, OH, OR, PA, SC, TN, TX, UT, VA, WA, WI, WV, and Guam. The products were distributed to the following foreign countries: Canada, United Arab Emirates and Saudi Arabia.

Code Information

Batch numbers: 16127933 17017602 17055977 17117153 17125385 18015788

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0387-2019
openFDA file date
Oct 23, 2026
Loaded by RegDataLab
Oct 24, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.